Jonas Kingo: Factor XI at the Crossroads of Hormonal Regulation and Thrombosis at ISTH 2026
Jonas Kingo, CEO at Aniara Holding, shared a post on LinkedIn:
“A new finding published in Blood (April 2026) adds an unexpected dimension to the FXI story — directly relevant to one of ISTH 2026‘s hottest topics.
Researchers discovered that estrogen upregulates lactoferrin — an iron-binding glycoprotein traditionally associated with innate immunity — which in turn potentiates FXIa activity.
This mechanism may help explain why elevated estrogen levels correlate with elevated VTE risk in pregnancy, oral contraceptive use, and postmenopausal hormone therapy.
The significance: it reframes our understanding of hormonal regulation of coagulation and introduces FXI as a potential therapeutic target for thrombosis prevention in hormonal contexts — without necessarily impairing normal hemostasis.
This connects directly to the broader FXI inhibitor story dominating Phase 3 trials right now.
Current evidence suggests FXI is mostly dispensable for hemostasis but essential for thrombosis — and the lactoferrin link suggests its regulation is more complex and biologically integrated than previously understood.
Expect this to generate significant discussion in Paris.”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome
-
Nov 17, 2026, 13:37Abdlemewla Ibrahim: Prasugrel vs Ticagrelor in ACS Patients Undergoing PCI
-
Nov 17, 2026, 13:30Stacy E. Croteau: Oral and Dental Care in Pediatric Patients With Bleeding Disorders
-
Nov 17, 2026, 13:19Efe Saglam: Cannabis Use and Cardiac Conduction
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation